Allergy medication and IBS can interact in ways that significantly affect digestive comfort and bowel habits. Antihistamines — the most commonly used allergy treatments — block histamine H1 receptors throughout the body, including in the gut, where histamine plays a role in regulating motility and fluid balance. For people already living with irritable bowel syndrome (IBS), this can mean that allergy treatment either worsens existing symptoms or, in some cases, may offer unexpected relief. Understanding how different allergy medications affect the gut, and how to manage both conditions simultaneously, is essential for making informed treatment choices in line with NHS and NICE guidance.
Summary: Allergy medications, particularly first-generation antihistamines, can worsen IBS symptoms by slowing gut motility through anticholinergic effects, while second-generation antihistamines and intranasal corticosteroids are generally better tolerated in people with IBS.
- First-generation antihistamines (e.g. chlorphenamine) have strong anticholinergic properties that can slow gut motility, causing constipation and bloating — symptoms that overlap with IBS-C.
- Second-generation antihistamines (e.g. loratadine, fexofenadine) carry a lower anticholinergic burden and are recommended as first-line allergy treatment by NICE CKS for allergic rhinitis and urticaria.
- Intranasal corticosteroids (e.g. fluticasone) act locally in the nasal passages with minimal systemic absorption and are unlikely to directly affect gut function, making them a preferred option for persistent allergic rhinitis.
- Histamine may play a role in IBS pathophysiology via mast cell activation and visceral hypersensitivity, though this evidence remains preliminary and should not be regarded as established causality.
- Combining anticholinergic allergy medications with anticholinergic antispasmodics (e.g. hyoscine butylbromide) increases the risk of constipation, urinary retention, and confusion, particularly in older adults.
- Red-flag symptoms such as rectal bleeding, unintentional weight loss, or an abdominal mass require prompt GP assessment and are not consistent with IBS — urgent referral thresholds are outlined in NICE NG12.
Table of Contents
Am I eligible for weight loss injections?
Find out whether you might be eligible!
Answer a few quick questions to see whether you may be suitable for prescription weight loss injections (like Wegovy® or Mounjaro®).
- No commitment — just a quick suitability check
- Takes about 1 minute to complete
How Allergy Medications Can Affect the Gut
Allergy medications — particularly antihistamines — work by blocking histamine H1 receptors throughout the body. It is important to note that commonly used allergy antihistamines are H1 receptor antagonists; they do not materially suppress gastric acid secretion, which is mediated by H2 receptors (targeted by a separate class of medicines, such as ranitidine or famotidine). Histamine H1 receptors are, however, involved in regulating gut motility and intestinal fluid balance, and when H1 antihistamines interfere with these processes, gastrointestinal side effects can follow. These effects may be particularly noticeable in people who already have a sensitive digestive system, such as those living with irritable bowel syndrome (IBS).
First-generation antihistamines, such as chlorphenamine, cross the blood-brain barrier and have broader anticholinergic effects. These effects can slow gut motility, leading to constipation, bloating, and abdominal discomfort — symptoms that overlap significantly with IBS. Second-generation antihistamines, such as cetirizine and loratadine, are generally considered less sedating and have fewer anticholinergic properties, but they are not entirely free from gastrointestinal effects, as detailed in their Summary of Product Characteristics (SmPC) documents available via the Electronic Medicines Compendium (eMC).
It is also worth noting that histamine has been proposed as a factor in IBS pathophysiology. Some research suggests that mast cell activation and local histamine release in the gut mucosa may contribute to visceral hypersensitivity and altered bowel habits in some people with IBS. However, this evidence remains limited and heterogeneous; it should be regarded as hypothesis-generating rather than established causality. This creates a complex relationship: the very substance that allergy medications target may also play a role in IBS symptoms, meaning that allergy treatment could, in some cases, affect the gut in both helpful and unhelpful ways. There is no officially established clinical link between antihistamine use and worsening IBS as a diagnosis, but individual responses can vary considerably. Patients and healthcare professionals can report suspected side effects to the MHRA via the Yellow Card Scheme (yellowcard.mhra.gov.uk).
Common Antihistamines and Their IBS-Related Side Effects
Understanding which antihistamines are most likely to affect the gut can help patients and clinicians make more informed choices. The following provides an overview of commonly used allergy medications and their potential gastrointestinal effects, based on individual SmPCs available via the eMC:
First-generation antihistamines (e.g., chlorphenamine, promethazine):
-
Strong anticholinergic activity, which can reduce intestinal motility
-
More likely to cause constipation, dry mouth, and nausea
-
May potentially worsen IBS-C (constipation-predominant IBS) symptoms in susceptible individuals
-
Generally not recommended for long-term allergy management
Second-generation antihistamines (e.g., cetirizine, loratadine, fexofenadine):
-
Lower anticholinergic burden, making them preferable for most patients
-
Cetirizine has been associated with nausea and, less commonly, diarrhoea in some individuals (see cetirizine SmPC)
-
Loratadine and fexofenadine tend to have a more favourable gastrointestinal profile
-
NICE CKS (Allergic rhinitis; Urticaria) recommends non-sedating second-generation antihistamines as first-line treatment for allergic rhinitis and urticaria
-
Note on UK availability: fexofenadine 120 mg is a Pharmacy (P) medicine available without prescription; higher-strength formulations remain prescription-only (POM)
Intranasal corticosteroids (e.g., fluticasone, beclometasone):
-
Primarily act locally in the nasal passages with minimal systemic absorption
-
Unlikely to directly affect gut function
-
NICE CKS recommends intranasal corticosteroids as the preferred option for persistent or moderate-to-severe allergic rhinitis, as they are generally more effective than oral antihistamines for nasal symptoms and avoid systemic antihistamine side effects altogether
For people with IBS, particularly those with constipation-predominant symptoms, choosing a second-generation antihistamine or an intranasal corticosteroid where appropriate may help minimise the risk of exacerbating bowel symptoms. Individual responses vary, and monitoring is important. It is important to read the patient information leaflet supplied with any medication and to discuss any new or worsening gastrointestinal symptoms with a pharmacist or GP, as these could reflect a side effect of the medication rather than a change in the underlying IBS.
Managing IBS Symptoms Alongside Allergy Treatment
For individuals managing both IBS and allergic conditions, a coordinated approach to treatment is essential. The first step is to identify whether any gastrointestinal symptoms are being driven or worsened by allergy medication, or whether they represent a flare of underlying IBS. Keeping a symptom diary — noting bowel habits, food intake, allergy medication use, and symptom severity — can be a practical and informative tool to share with a healthcare professional.
Before a diagnosis of IBS is confirmed, NICE guideline CG61 (Irritable bowel syndrome in adults) recommends that coeliac disease is excluded by checking coeliac serology (tissue transglutaminase antibody, tTG), alongside basic blood tests including full blood count (FBC) and inflammatory markers (CRP or ESR).
Lifestyle and dietary measures remain central to IBS management, regardless of allergy treatment. NICE CG61 recommends that patients with IBS consider:
-
Dietary adjustments, such as reducing fermentable carbohydrates (the low-FODMAP diet, ideally under dietitian supervision — see British Dietetic Association guidance)
-
Regular physical activity, which supports gut motility
-
Adequate hydration, particularly important if antihistamines are contributing to constipation
-
Stress management, as psychological factors are well recognised to influence IBS symptom severity
For symptom-specific pharmacological management, NICE CG61 recommends:
-
Antispasmodics (e.g., mebeverine, peppermint oil) for abdominal pain and cramping
-
Loperamide as first-line treatment for IBS-D (diarrhoea-predominant IBS)
-
Macrogol laxatives (e.g., macrogol 3350, such as Movicol) for IBS-C (constipation-predominant IBS), with dose titration as needed; longer-term use may be appropriate under pharmacist or GP guidance
-
Lactulose should be avoided in IBS, as it can worsen bloating and flatulence
-
Linaclotide may be considered for refractory IBS-C under specialist or GP supervision
If constipation is a concern whilst taking antihistamines, increasing soluble dietary fibre (such as oats and linseeds, which are generally better tolerated in IBS than insoluble fibre) and fluid intake may help alongside any laxative treatment.
For allergy management, non-pharmacological strategies such as allergen avoidance, nasal saline irrigation, and the use of antihistamine eye drops or nasal sprays (rather than oral tablets) may reduce systemic exposure and limit gut-related side effects. Switching antihistamine agents — for example, from cetirizine to fexofenadine — under pharmacist guidance may also be worth considering if gastrointestinal symptoms are troublesome.
When to Seek Advice from a GP or Pharmacist
Most people managing mild allergy symptoms alongside IBS can do so safely with over-the-counter medications and self-care strategies. However, there are circumstances where professional advice should be sought promptly. A pharmacist is an excellent first point of contact for medication-related queries and can advise on suitable antihistamine choices, potential interactions, and symptom management without the need for a GP appointment.
Contact a GP or pharmacist if you experience:
-
New or significantly worsening gastrointestinal symptoms after starting an allergy medication
-
Persistent constipation or diarrhoea that does not respond to self-care measures
-
Unexplained abdominal pain, bloating, or changes in bowel habit lasting more than a few weeks
-
Difficulty managing both conditions simultaneously, or uncertainty about which medication is causing which symptom
Seek urgent medical attention — contact your GP promptly or attend urgent care — if you notice any of the following red-flag symptoms, which are not typical of IBS and require further investigation in line with NICE guideline CG61 and NICE NG12 (Suspected cancer: recognition and referral):
-
Blood in your stools or rectal bleeding (particularly in people aged 50 and over with unexplained rectal bleeding, or aged 60 and over with a change in bowel habit or iron-deficiency anaemia — urgent referral thresholds apply per NICE NG12)
-
Unintentional weight loss, especially when accompanied by abdominal pain (particularly in people aged 40 and over)
-
Iron-deficiency anaemia
-
An abdominal or rectal mass
-
Persistent vomiting or unexplained fever
-
A family history of bowel cancer or ovarian cancer, which may lower the threshold for investigation
-
Nocturnal symptoms that wake you from sleep, which are atypical for IBS
-
Symptoms suggesting coeliac disease (e.g., diarrhoea, bloating, and fatigue), which should be excluded by blood test before an IBS diagnosis is confirmed
Your GP may arrange a faecal immunochemical test (FIT) and other investigations where appropriate, in line with NICE NG12 guidance.
Seek emergency medical attention (call 999) if you develop symptoms of a severe allergic reaction (anaphylaxis), including throat swelling, difficulty breathing, or collapse.
It is also important to inform your GP or pharmacist of all medications you are taking, including over-the-counter antihistamines, as these can interact with other drugs used in IBS management. In particular, antispasmodics such as hyoscine butylbromide also have anticholinergic properties; combining anticholinergic medications can increase the risk of side effects such as constipation, urinary retention, and confusion, particularly in older adults (see BNF guidance on anticholinergic burden). Suspected side effects from any medication can be reported to the MHRA via the Yellow Card Scheme at yellowcard.mhra.gov.uk.
NICE and NHS Guidance on Treating Allergies with IBS
NICE provides clear guidance on the management of both allergic conditions and IBS, though specific guidance addressing the co-management of both conditions simultaneously is limited. For allergic rhinitis, NICE CKS (Allergic rhinitis) recommends non-sedating second-generation antihistamines as first-line treatment, with intranasal corticosteroids preferred for persistent or moderate-to-severe symptoms, as they are generally more effective for nasal symptoms. For urticaria, NICE CKS (Urticaria) similarly recommends non-sedating H1 antihistamines as first-line. These recommendations align well with the needs of people with IBS, as these options carry a lower risk of anticholinergic gut effects compared with older, first-generation antihistamines.
For IBS, NICE guideline CG61 (Irritable bowel syndrome in adults) outlines a stepwise approach to management, emphasising lifestyle modification, dietary change, and pharmacological treatment tailored to the predominant symptom (diarrhoea, constipation, or pain). The guideline does not specifically address the impact of allergy medications on IBS, but the general principle of minimising polypharmacy and anticholinergic burden is consistent with good prescribing practice across NHS settings. Particular care should be taken in older adults, in whom cumulative anticholinergic burden is associated with an increased risk of adverse effects including constipation, urinary retention, and cognitive impairment (see BNF guidance).
The MHRA and the Electronic Medicines Compendium (eMC) provide detailed SmPC information on the side effect profiles of individual antihistamines, which clinicians and patients can use to make informed decisions. The NHS also offers accessible information on both IBS and allergies through NHS.uk, encouraging patients to seek advice from their GP if symptoms are difficult to manage or if they are unsure about the suitability of a particular medication.
In summary, whilst there is no specific NICE pathway for managing allergy medication and IBS together, the overarching principles of evidence-based prescribing — choosing medications with the most favourable side effect profile, using the lowest effective dose, regularly reviewing treatment, and minimising anticholinergic burden — apply equally here. Patients are encouraged to engage actively with their GP or pharmacist to find an approach that effectively controls allergy symptoms without unnecessarily compromising their digestive health. Suspected adverse drug reactions should be reported to the MHRA via the Yellow Card Scheme (yellowcard.mhra.gov.uk).
Key UK references:
-
NICE CKS: Allergic rhinitis (cks.nice.org.uk)
-
NICE CKS: Urticaria (cks.nice.org.uk)
-
NICE CG61: Irritable bowel syndrome in adults (nice.org.uk)
-
NICE NG12: Suspected cancer — recognition and referral (nice.org.uk)
-
NHS: Irritable bowel syndrome (nhs.uk)
-
NHS: Hay fever (allergic rhinitis) (nhs.uk)
-
eMC SmPCs for chlorphenamine, cetirizine, loratadine, and fexofenadine (medicines.org.uk)
-
BNF: Antihistamines and laxatives (bnf.nice.org.uk)
-
MHRA Yellow Card Scheme (yellowcard.mhra.gov.uk)
Frequently Asked Questions
Can allergy medication make my IBS worse?
Yes, certain allergy medications — particularly first-generation antihistamines such as chlorphenamine — can worsen IBS symptoms by slowing gut motility through their anticholinergic effects, leading to constipation, bloating, and abdominal discomfort. Second-generation antihistamines like loratadine and fexofenadine have a much lower anticholinergic burden and are less likely to aggravate bowel symptoms, making them a preferable choice for most people with IBS.
Which antihistamine is safest to take if I have IBS?
Non-sedating second-generation antihistamines such as loratadine and fexofenadine are generally considered the safest options for people with IBS, as they have fewer anticholinergic effects that could disrupt gut motility. NICE CKS recommends these as first-line treatment for allergic rhinitis and urticaria, and for persistent nasal symptoms, an intranasal corticosteroid such as fluticasone may be even better as it avoids systemic effects on the gut altogether.
Could antihistamines actually help IBS symptoms in some people?
There is emerging research suggesting that histamine released by mast cells in the gut lining may contribute to visceral hypersensitivity and altered bowel habits in some people with IBS, which raises the possibility that antihistamines could be beneficial in certain cases. However, this evidence is preliminary and not yet sufficient to support antihistamines as a treatment for IBS; they are not recommended for this purpose in current NICE guidance, and individual responses vary considerably.
Is it safe to take an antispasmodic for IBS at the same time as an antihistamine?
Combining antihistamines with anticholinergic antispasmodics such as hyoscine butylbromide can increase the overall anticholinergic burden on the body, raising the risk of side effects including constipation, urinary retention, dry mouth, and — particularly in older adults — confusion. It is important to inform your pharmacist or GP of all medications you are taking, including over-the-counter antihistamines, so they can assess the combined effect and recommend the safest approach.
How do I know if my gut symptoms are a side effect of my allergy medication or a flare of my IBS?
Keeping a symptom diary that records bowel habits, food intake, allergy medication use, and symptom severity can help identify whether gut symptoms coincide with starting or changing allergy medication, suggesting a drug side effect rather than an IBS flare. If symptoms are new, significantly worsening, or do not settle with self-care, a pharmacist or GP can help distinguish between a medication side effect and an underlying change in your IBS.
How do I get the right allergy medication for IBS from my GP or pharmacist?
A pharmacist is an excellent first point of contact and can recommend a suitable over-the-counter antihistamine — such as loratadine or fexofenadine — that is less likely to affect your bowel symptoms, without the need for a GP appointment. If your allergy symptoms are persistent or moderate-to-severe, or if over-the-counter options are not controlling your symptoms adequately, your GP can prescribe an intranasal corticosteroid or review your overall treatment plan in line with NICE guidance.
The health-related content published on this site is based on credible scientific sources and is periodically reviewed to ensure accuracy and relevance. Although we aim to reflect the most current medical knowledge, the material is meant for general education and awareness only.
The information on this site is not a substitute for professional medical advice. For any health concerns, please speak with a qualified medical professional. By using this information, you acknowledge responsibility for any decisions made and understand we are not liable for any consequences that may result.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Heading 6
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur.
Block quote
Ordered list
- Item 1
- Item 2
- Item 3
Unordered list
- Item A
- Item B
- Item C
Bold text
Emphasis
Superscript
Subscript
